S159: HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA AFTER DISCONTINUATION OF TYROSINE KINASE INHIBITORS: RESULTS FROM THE EURO-SKI STUDY
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000967548.09724.54 |
| _version_ | 1827331459921215488 |
|---|---|
| author | Fabio Efficace Francois-Xavier Mahon Johan Richter Alfonso Piciocchi Marta Cipriani Franck Emmanuel Nicolini Henrik Hjorth-Hansen Antonio Almeida Jeroen J. W. M. Janssen Jiri Mayer Perttu Koskenvesa Panayiotis Panayiotidis Ulla Olsson-Strömberg Joaquín Martinez-Lopez Philippe Rousselot Hanne Vestergaard Hans Ehrencrona Veli Kairisto Katerina Machova Polakova Satu Mustjoki Marc Berger Andreas Hochhaus Markus Pfirrmann Susanne Saussele |
| author_facet | Fabio Efficace Francois-Xavier Mahon Johan Richter Alfonso Piciocchi Marta Cipriani Franck Emmanuel Nicolini Henrik Hjorth-Hansen Antonio Almeida Jeroen J. W. M. Janssen Jiri Mayer Perttu Koskenvesa Panayiotis Panayiotidis Ulla Olsson-Strömberg Joaquín Martinez-Lopez Philippe Rousselot Hanne Vestergaard Hans Ehrencrona Veli Kairisto Katerina Machova Polakova Satu Mustjoki Marc Berger Andreas Hochhaus Markus Pfirrmann Susanne Saussele |
| author_sort | Fabio Efficace |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:36:32Z |
| format | Article |
| id | doaj.art-a078e335813f413cb617882efe61628c |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:36:32Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-a078e335813f413cb617882efe61628c2024-03-03T09:43:29ZengWileyHemaSphere2572-92412023-08-017e097245410.1097/01.HS9.0000967548.09724.54202308003-00061S159: HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA AFTER DISCONTINUATION OF TYROSINE KINASE INHIBITORS: RESULTS FROM THE EURO-SKI STUDYFabio Efficace0Francois-Xavier Mahon1Johan Richter2Alfonso Piciocchi3Marta Cipriani4Franck Emmanuel Nicolini5Henrik Hjorth-Hansen6Antonio Almeida7Jeroen J. W. M. Janssen8Jiri Mayer9Perttu Koskenvesa10Panayiotis Panayiotidis11Ulla Olsson-Strömberg12Joaquín Martinez-Lopez13Philippe Rousselot14Hanne Vestergaard15Hans Ehrencrona16Veli Kairisto17Katerina Machova Polakova18Satu Mustjoki19Marc Berger20Andreas Hochhaus21Markus Pfirrmann22Susanne Saussele231 Italian Group for Adult Haematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy2 Institut Bergonié, Service d’Hématologie Clinique, Bordeaux, France3 Skåne University Hospital, Department of Hematology, Oncology and Radiation Physics, Lund, Sweden1 Italian Group for Adult Haematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy1 Italian Group for Adult Haematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy5 Centre Léon Bérard, Service d’Hématologie Clinique & INSERM U1052 CRCL, Lyon, France6 St Olavs Hospital, Department of Hematology, Trondheim, Norway7 Hospital da Luz, Faculdade de Medicina, Universidade Católica Portuguesa, Department of Hematology, Lisbon, Portugal8 Radboud UMC, Department of Haematology, Nijmegen, The Netherlands9 Masaryk University Hospital, Department of Internal Medicine, Hematology and Oncology, Brno, Czech Republic10 Hematology Research Unit Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Department of Hematology, Helsinki, Finland11 National and Kapodistrian University of Athens, First Propedeutic Department of Internal Medicine, Athens, Greece12 Uppsala University Hospital, Department of Medical Sciences, Uppsala University and Hematology Section, Uppsala, Sweden13 Universidad Complutense de Madrid, Hematology, Hospital Universitario 12 de Octubre, CNIO, Madrid, Spain14 CH Versailles, Department of Haemato-Oncology, Versailles, France15 Odense University Hospital, Quality of Life Research Center, Department of Haematology, Odense, Denmark16 Department of Clinical Genetics, Pathology and Molecular Diagnostics, Office for Medical Services, Region Skåne, Lund, Sweden; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden17 Turku University Central Hospital, Department of Clinical Chemistry and Department of Genetics, Turku, Finland18 Institute of Haematology and Blood Transfusion, Prague, Czech Republic19 University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Hematology Research Unit Helsinki, Helsinki, Finland20 CHU Estaing and Université Clermont Auvergne, Hématologie Biologique and Equipe d’Accueil 7453 Hemopaties Chroniques: Heterogeneite Intra-clonale, Microenvironnement et Resistance Therapeutique, Clermont-Ferrand, France21 Universitätsklinikum Jena, Klinik für Innere Medizin II, Jena, Germany22 Ludwig-Maximilians-Universität, Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Munich, Germany23 Heidelberg University, Department of Haematology and Oncology, University Hospital Mannheim, Mannheim, Germanyhttp://journals.lww.com/10.1097/01.HS9.0000967548.09724.54 |
| spellingShingle | Fabio Efficace Francois-Xavier Mahon Johan Richter Alfonso Piciocchi Marta Cipriani Franck Emmanuel Nicolini Henrik Hjorth-Hansen Antonio Almeida Jeroen J. W. M. Janssen Jiri Mayer Perttu Koskenvesa Panayiotis Panayiotidis Ulla Olsson-Strömberg Joaquín Martinez-Lopez Philippe Rousselot Hanne Vestergaard Hans Ehrencrona Veli Kairisto Katerina Machova Polakova Satu Mustjoki Marc Berger Andreas Hochhaus Markus Pfirrmann Susanne Saussele S159: HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA AFTER DISCONTINUATION OF TYROSINE KINASE INHIBITORS: RESULTS FROM THE EURO-SKI STUDY HemaSphere |
| title | S159: HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA AFTER DISCONTINUATION OF TYROSINE KINASE INHIBITORS: RESULTS FROM THE EURO-SKI STUDY |
| title_full | S159: HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA AFTER DISCONTINUATION OF TYROSINE KINASE INHIBITORS: RESULTS FROM THE EURO-SKI STUDY |
| title_fullStr | S159: HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA AFTER DISCONTINUATION OF TYROSINE KINASE INHIBITORS: RESULTS FROM THE EURO-SKI STUDY |
| title_full_unstemmed | S159: HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA AFTER DISCONTINUATION OF TYROSINE KINASE INHIBITORS: RESULTS FROM THE EURO-SKI STUDY |
| title_short | S159: HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA AFTER DISCONTINUATION OF TYROSINE KINASE INHIBITORS: RESULTS FROM THE EURO-SKI STUDY |
| title_sort | s159 health related quality of life of patients with chronic myeloid leukemia after discontinuation of tyrosine kinase inhibitors results from the euro ski study |
| url | http://journals.lww.com/10.1097/01.HS9.0000967548.09724.54 |
| work_keys_str_mv | AT fabioefficace s159healthrelatedqualityoflifeofpatientswithchronicmyeloidleukemiaafterdiscontinuationoftyrosinekinaseinhibitorsresultsfromtheeuroskistudy AT francoisxaviermahon s159healthrelatedqualityoflifeofpatientswithchronicmyeloidleukemiaafterdiscontinuationoftyrosinekinaseinhibitorsresultsfromtheeuroskistudy AT johanrichter s159healthrelatedqualityoflifeofpatientswithchronicmyeloidleukemiaafterdiscontinuationoftyrosinekinaseinhibitorsresultsfromtheeuroskistudy AT alfonsopiciocchi s159healthrelatedqualityoflifeofpatientswithchronicmyeloidleukemiaafterdiscontinuationoftyrosinekinaseinhibitorsresultsfromtheeuroskistudy AT martacipriani s159healthrelatedqualityoflifeofpatientswithchronicmyeloidleukemiaafterdiscontinuationoftyrosinekinaseinhibitorsresultsfromtheeuroskistudy AT franckemmanuelnicolini s159healthrelatedqualityoflifeofpatientswithchronicmyeloidleukemiaafterdiscontinuationoftyrosinekinaseinhibitorsresultsfromtheeuroskistudy AT henrikhjorthhansen s159healthrelatedqualityoflifeofpatientswithchronicmyeloidleukemiaafterdiscontinuationoftyrosinekinaseinhibitorsresultsfromtheeuroskistudy AT antonioalmeida s159healthrelatedqualityoflifeofpatientswithchronicmyeloidleukemiaafterdiscontinuationoftyrosinekinaseinhibitorsresultsfromtheeuroskistudy AT jeroenjwmjanssen s159healthrelatedqualityoflifeofpatientswithchronicmyeloidleukemiaafterdiscontinuationoftyrosinekinaseinhibitorsresultsfromtheeuroskistudy AT jirimayer s159healthrelatedqualityoflifeofpatientswithchronicmyeloidleukemiaafterdiscontinuationoftyrosinekinaseinhibitorsresultsfromtheeuroskistudy AT perttukoskenvesa s159healthrelatedqualityoflifeofpatientswithchronicmyeloidleukemiaafterdiscontinuationoftyrosinekinaseinhibitorsresultsfromtheeuroskistudy AT panayiotispanayiotidis s159healthrelatedqualityoflifeofpatientswithchronicmyeloidleukemiaafterdiscontinuationoftyrosinekinaseinhibitorsresultsfromtheeuroskistudy AT ullaolssonstromberg s159healthrelatedqualityoflifeofpatientswithchronicmyeloidleukemiaafterdiscontinuationoftyrosinekinaseinhibitorsresultsfromtheeuroskistudy AT joaquinmartinezlopez s159healthrelatedqualityoflifeofpatientswithchronicmyeloidleukemiaafterdiscontinuationoftyrosinekinaseinhibitorsresultsfromtheeuroskistudy AT philipperousselot s159healthrelatedqualityoflifeofpatientswithchronicmyeloidleukemiaafterdiscontinuationoftyrosinekinaseinhibitorsresultsfromtheeuroskistudy AT hannevestergaard s159healthrelatedqualityoflifeofpatientswithchronicmyeloidleukemiaafterdiscontinuationoftyrosinekinaseinhibitorsresultsfromtheeuroskistudy AT hansehrencrona s159healthrelatedqualityoflifeofpatientswithchronicmyeloidleukemiaafterdiscontinuationoftyrosinekinaseinhibitorsresultsfromtheeuroskistudy AT velikairisto s159healthrelatedqualityoflifeofpatientswithchronicmyeloidleukemiaafterdiscontinuationoftyrosinekinaseinhibitorsresultsfromtheeuroskistudy AT katerinamachovapolakova s159healthrelatedqualityoflifeofpatientswithchronicmyeloidleukemiaafterdiscontinuationoftyrosinekinaseinhibitorsresultsfromtheeuroskistudy AT satumustjoki s159healthrelatedqualityoflifeofpatientswithchronicmyeloidleukemiaafterdiscontinuationoftyrosinekinaseinhibitorsresultsfromtheeuroskistudy AT marcberger s159healthrelatedqualityoflifeofpatientswithchronicmyeloidleukemiaafterdiscontinuationoftyrosinekinaseinhibitorsresultsfromtheeuroskistudy AT andreashochhaus s159healthrelatedqualityoflifeofpatientswithchronicmyeloidleukemiaafterdiscontinuationoftyrosinekinaseinhibitorsresultsfromtheeuroskistudy AT markuspfirrmann s159healthrelatedqualityoflifeofpatientswithchronicmyeloidleukemiaafterdiscontinuationoftyrosinekinaseinhibitorsresultsfromtheeuroskistudy AT susannesaussele s159healthrelatedqualityoflifeofpatientswithchronicmyeloidleukemiaafterdiscontinuationoftyrosinekinaseinhibitorsresultsfromtheeuroskistudy |